EUVIMEDEUVIMED entdecken
Open Access

Benefits, Harms, and Burden of Colorectal Cancer Screening Among Childhood Cancer Survivors Previously Treated With Abdominopelvic Radiation

Jennifer M Yeh iD, Claudia L Seguin iD, Kayla L Stratton iD, Wendy M Leisenring iD, Gregory T Armstrong, Tara O Henderson iD, Melissa M Hudson iD, Paul C Nathan iD, Joseph P Neglia iD, Kevin C Oeffinger iD, Lisa R Diller, Amy B Knudsen iD

Journal of Clinical Oncology · 2026

DOI: 10.1200/jco-25-00661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2026. Verfasst von Jennifer M Yeh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Boston Children's Hospital, Boston, MA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Cancer Survivors. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Childhood cancer survivors treated with abdominopelvic radiation (RT) are at increased risk of colorectal cancer (CRC), yet adherence to Children's Oncology Group screening guidelines remains low. Estimating the benefits, burdens, and costs of all guideline-recommended screening modalities, including those not previously evaluated, may help identify strategies that align with survivors' preferences and access, potentially improving adherence. METHODS Using data from the Childhood Cancer Survivor Study and published studies, we adapted a CRC simulation model to evaluate CRC screening among 5-year survivors. Strategies included colonoscopy, multitarget stool DNA (mtsDNA), and fecal immunochemical testing (FIT) at various intervals, starting at age 25-45 years. Outcomes included CRC cases and deaths, additional colonoscopies per additional life-year gained (burden-to-benefit ratio [BBR]), and cost per quality-adjusted life-year gained (QALYG; incremental cost-effectiveness ratios [ICERs]). RESULTS At age 45 years, survivors had a 0.6% cumulative CRC risk (relative risk, 3.3 v average-risk individuals). Without screening, an estimated 75 per 1,000 survivors would be diagnosed with CRC in their lifetime and 30 would die from CRC. Screening averted 47-73 cases and 23-29 CRC deaths per 1,000. Based on average-risk BBR benchmarks, the optimal strategies by modality were colonoscopy every 10 years starting at age 30 years, mtsDNA every 3 years starting at age 30 years, and FIT every 3 years starting at age 25 years (then annually as of age 45 years, as recommended for average-risk individuals). ICERs were $146,000 in US dollars (USD)/QALYG, $166,000 (USD)/QALYG, and $123,000 (USD)/QALYG, respectively. CONCLUSION Early initiation of screening with colonoscopy or stool-based tests may substantially reduce CRC incidence and early mortality among survivors treated with abdominopelvic RT, with reasonable burden-to-benefit trade-offs, and be considered cost-effective. These findings can facilitate clinician-survivor discussions on CRC screening and inform guideline refinements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerCancer SurvivorsHumansAdultMiddle AgedCost-Benefit AnalysisFemaleMaleQuality-Adjusted Life YearsColonoscopyChildPelvis

Autor:innen und Institutionen

  • Boston Children's Hospital, Boston, MA.
  • Harvard Medical School, Boston, MA.
  • Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA.
  • Fred Hutchinson Cancer Center, Seattle, WA.
  • St Jude Children's Research Hospital, Memphis, TN.
  • Lurie Children's Hospital and Northwestern University, Chicago, IL.

ORCID-Profile: Jennifer M Yeh, Claudia L Seguin, Kayla L Stratton, Wendy M Leisenring, Tara O Henderson, Melissa M Hudson, Paul C Nathan, Joseph P Neglia, Kevin C Oeffinger, Amy B Knudsen

Förderung

  • NCI NIH HHS

Zitieren

APA

Yeh, J. M., Seguin, C. L., Stratton, K. L., Leisenring, W. M., Armstrong, G. T., Henderson, T. O., Hudson, M. M., Nathan, P. C., Neglia, J. P., Oeffinger, K. C., Diller, L. R., & Knudsen, A. B. (2026). Benefits, Harms, and Burden of Colorectal Cancer Screening Among Childhood Cancer Survivors Previously Treated With Abdominopelvic Radiation. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00661

Vancouver

Yeh JM, Seguin CL, Stratton KL, Leisenring WM, Armstrong GT, Henderson TO, et al. Benefits, Harms, and Burden of Colorectal Cancer Screening Among Childhood Cancer Survivors Previously Treated With Abdominopelvic Radiation. Journal of Clinical Oncology. 2026. doi:10.1200/jco-25-00661

BibTeX
@article{Yeh2026,
  author = {Yeh, Jennifer M and Seguin, Claudia L and Stratton, Kayla L and Leisenring, Wendy M and Armstrong, Gregory T and Henderson, Tara O and Hudson, Melissa M and Nathan, Paul C and Neglia, Joseph P and Oeffinger, Kevin C and Diller, Lisa R and Knudsen, Amy B},
  title = {Benefits, Harms, and Burden of Colorectal Cancer Screening Among Childhood Cancer Survivors Previously Treated With Abdominopelvic Radiation},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1200/jco-25-00661}
}
Kostenlos starten →